Bio-electrode and method for manufacturing bio-electrode
A bioelectrode with a micropillar-ionic polymer structure addresses conductivity and biocompatibility issues, ensuring long-term, comfortable, and cost-effective biosignal monitoring.
Patent Information
- Application Number
- JP2024062219
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-04-26
- Filing Date
- 2024-04-08
- Publication Date
- 2024-11-08
AI Technical Summary
Existing bioelectrodes used in wearable medical devices face challenges such as loss of conductivity due to drying, skin allergies, high impedance, and poor biocompatibility, making them unsuitable for long-term, comfortable, and cost-effective use.
A bioelectrode with a biocontact layer containing micropillars and an ionic polymer made from fluorosulfonic acid, fluorosulfonimide, or fluorosulfonamide, which maintains conductivity and biocompatibility, even when wet or dry, and is lightweight and comfortable to wear.
The bioelectrode maintains high sensitivity to biological signals, is lightweight, and does not cause skin irritation, even after prolonged use, while being cost-effective and easy to manufacture.
Smart Images

Figure 2024159544000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a bioelectrode and a method for manufacturing a bioelectrode. [Background technology]
[0002] In recent years, the development of wearable devices has progressed with the spread of IoT (Internet of Things). Wearable devices that can constantly monitor the condition of the body are also needed in the medical and sports fields, and are expected to be a growth field in the future. In particular, the global spread of the new coronavirus (COVID-19) has placed a serious burden on medical care, and there are calls for the necessity and acceleration of home medical care for people who are not infected with the virus.
[0003] In the medical field, wearable devices that monitor the state of the body's organs by sensing weak currents, such as electrocardiograms, which sense the movement of the heart through electrical signals, are available. In electrocardiograms, electrodes coated with hydrated gel are attached to the body to perform the measurement, but this is a one-time, short-term measurement. In contrast, the development of medical wearable devices such as those mentioned above aims to develop devices that constantly monitor health conditions for several weeks. Therefore, bioelectrodes used in medical wearable devices are required to be able to collect biosignals even when used for long periods of time in daily life, such as showering, bathing, and sweating, to be comfortable and not cause itching or skin allergies, and to be lightweight and thin enough to be unnoticeable when worn, and to be able to be manufactured at low cost and with high productivity.
[0004] Wearable medical devices include those that are attached to the body and those that are incorporated into clothing. As for the type that is attached to the body, a bioelectrode that uses a water-soluble gel containing water and electrolytes, which are materials for conductive paste, has been proposed (Patent Document 1). The water-soluble gel contains sodium, potassium, and calcium as electrolytes in a water-soluble polymer that holds water, and converts changes in ion concentration from the skin into electricity. On the other hand, as for the type that is incorporated into clothing, a method has been proposed that uses a conductive polymer such as PEDOT-PSS (Poly-3,4-ethylenedioxythiophene-Polystyrenesulfonate) or cloth with silver paste incorporated into the fibers as an electrode (Patent Document 2).
[0005] However, when using the above-mentioned water-soluble gel containing water and electrolytes, there is a problem that the conductivity is lost when the water dries out. On the other hand, when using metals with a high ionization tendency such as copper, there is a problem that some people may develop skin allergies, and when using conductive polymers such as PEDOT-PSS, there is a problem that the conductive polymer is highly acidic and therefore may develop skin allergies, and the conductive polymer may peel off from the fibers during washing.
[0006] In addition, because of their excellent electrical conductivity, the use of metal nanowires, carbon black, carbon nanotubes, and the like as electrode materials has also been considered (Patent Documents 3, 4, 5). Metal nanowires have a high probability of contact between wires, so they can conduct electricity with a small amount of additive. However, metal nanowires are thin materials with sharp tips, which can cause skin allergies. Thus, even if the material itself does not cause an allergic reaction, the shape and irritation of the material can cause the material to have poor biocompatibility, making it difficult to achieve both electrical conductivity and biocompatibility.
[0007] Metal films are highly conductive and one would think they would function as excellent bioelectrodes, but this is not necessarily the case. When the heart beats, not only a weak current is released from the skin, but also sodium ions, potassium ions, and calcium ions. For this reason, it is necessary to convert the change in ion concentration into an electric current, but precious metals, which are difficult to ionize, are inefficient at converting ions from the skin into an electric current. Therefore, bioelectrodes using precious metals have a high impedance, and there is a high resistance to electrical current passing through the skin.
[0008] A bioelectrode also needs to have adhesiveness, which allows accurate biosignals to be obtained even when the body is moving (Non-Patent Document 1).
[0009] Bioelectrode materials in which ionic polymers are mixed with silicone adhesives have been proposed (Patent Documents 6 and 7). These materials not only have high ionic conductivity, but also have high electronic conductivity when conductive powders such as carbon and silver are added, so they function as excellent bioelectrodes. By combining silicone adhesives, which have low skin allergies, high water repellency, and the effect of suppressing itching and redness of the skin after removal, with ionic polymers that have high ionic conductivity and do not pass through the skin, it is possible to obtain stable biosignals without peeling off even when attached for a long period of time, including daily bathing and exercise, but there is a demand for further improvement in comfort when attached for a long period of time.
[0010] Geckos can climb vertical window panes without any handholds. The Van der Waals force between the fine hairs on the soles of their feet and the surface of the window pane allows them to move without falling off the pane (Non-Patent Document 2). Using this principle, an adhesive bioelectrode has been proposed in which silicone containing conductive particles such as silver is processed into a tiny mushroom shape (Non-Patent Document 3).
[0011] A method for producing a mold for creating the cilia of a gecko's foot has been proposed (Patent Document 8). The production of an adhesive sheet in the shape of a gecko's foot using a mold has the advantage of high productivity.
[0012] When creating the mushroom-shaped cilia of a gecko's foot, which have a wide tip, using a mold, there is a possibility that the cilia will be torn off due to stress applied to the cilia when the mold is peeled off. In order to reduce the stress during peeling, a method of peeling off a curved base material has been proposed (Patent Document 9). [Prior art documents] [Patent documents]
[0013] [Patent Document 1] International Publication No. 2013 / 039151 [Patent Document 2] JP 2015-100673 A [Patent Document 3] Japanese Patent Application Publication No. 05-095924 [Patent Document 4] JP 2003-225217 A [Patent Document 5] JP 2015-019806 A [Patent Document 6] JP 2018-126496 A [Patent Document 7] JP 2018-130533 A [Patent Document 8] Special Publication No. 2023-501603 [Patent Document 9] U.S. Patent No. 9,566,722 [Non-patent literature]
[0014] [Non-Patent Document 1] JOM Vol.68,No.4,p1145,(2016) [Non-Patent Document 2] Nature Vol.405, p681, June(2000) [Non-Patent Document 3] Adv.Healthcare Mater.(2018),7,1700994 Summary of the Invention [Problem to be solved by the invention]
[0015] The present invention has been made to solve the above problems, and aims to provide a bioelectrode that is thin and highly transparent, has good adhesion to living organisms, has high sensitivity to biosignals, is highly biocompatible, is lightweight, and can be manufactured at low cost, and does not significantly reduce the sensitivity of biosignals even when wet or dry, or when attached to the skin for a long period of time, and is comfortable to use without causing itching, red spots, rashes, etc., on the skin, and a method for manufacturing the bioelectrode. [Means for solving the problem]
[0016] In order to solve the above problems, the present invention provides a bioelectrode including a biological contact layer and a substrate, The biological contact layer has micropillars having a diameter of 0.01 to 500 μm and a height of 0.1 to 1,000 μm, and contains an ionic polymer (A) as a material; The component (A) includes one or more repeating units a selected from fluorosulfonic acid, fluorosulfonimide, and fluorosulfonamide, and has a weight-average molecular weight in the range of 1,000 to 500,000.
[0017] Such a bioelectrode is thin and highly transparent, has good adhesion to the living body, is highly sensitive to biosignals, has excellent biocompatibility, is lightweight, and can be manufactured at low cost. The sensitivity of the biosignals does not decrease significantly even when it gets wet or dry, or when it is attached to the skin for a long period of time, making it a comfortable bioelectrode that does not cause itching, red spots, or rashes on the skin.
[0018] In the present invention, the repeating unit a preferably has a partial structure represented by the following general formulae (1)-1 to (1)-4. [ka] (In the formula, Rf1 and Rf2 are a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group. When Rf1 and Rf2 are oxygen atoms, Rf1 and Rf2 are one oxygen atom bonding to one carbon atom to form a carbonyl group. Rf3 and Rf4 are a hydrogen atom, a fluorine atom, or a trifluoromethyl group. One or more of Rf1 to Rf4 are a fluorine atom or a trifluoromethyl group. Rf5 is a fluorine atom, or a linear or branched alkyl group having 1 to 4 carbon atoms and has at least one fluorine atom. Rf6 and Rf7 are a linear, branched, or cyclic alkyl group having 1 to 10 carbon atoms which may be substituted with a fluorine atom, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms and has at least one fluorine atom. M + is an ion selected from an ammonium ion, a sodium ion, a potassium ion, and a silver ion; and m is an integer of 1 to 4.
[0019] If the repeating unit a has such a structure, a bioelectrode having superior electrical conductivity and biocompatibility can be obtained.
[0020] In the present invention, the repeating unit a preferably has one or more repeating units selected from the repeating units A1 to A4 represented by the following general formula (2). [ka] (In general formula (2), R 1 , R 3 , R 4 , and R 6 are each independently a hydrogen atom or a methyl group, R 2 , R 5 , and R 7are each independently a single bond, or a linear, branched or cyclic hydrocarbon group having 1 to 13 carbon atoms, and may have an ester group, an ether group, or both. X1, X2, X3, and X4 are each independently a single bond, a phenylene group, a naphthylene group, an ether group, an ester group, or an amide group. Rf1 and Rf2 are a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group, and when Rf1 and Rf2 are oxygen atoms, Rf1 and Rf2 are an oxygen atom that bonds to one carbon atom to form a carbonyl group, and Rf3 and Rf4 are a hydrogen atom, a fluorine atom, or a trifluoromethyl group, and at least one of Rf1 to Rf4 is a fluorine atom or a trifluoromethyl group. Rf5 is a fluorine atom, or a linear or branched alkyl group having 1 to 4 carbon atoms, and has at least one fluorine atom. Rf6 and Rf7 are a linear, branched or cyclic alkyl group having 1 to 10 carbon atoms, which may be substituted with a fluorine atom, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms, and have at least one fluorine atom. m is an integer of 1 to 4. a1, a2, a3 and a4 are each 0≦a1≦1.0, 0≦a2≦1.0, 0≦a3≦1.0 and 0≦a4≦1.0, and 0≦a1≦1.0 is an integer of 1 to 4. <a1+a2+a3+a4≦1.0である。M + is an ion selected from ammonium ion, sodium ion, potassium ion, and silver ion.
[0021] If the repeating unit a has such a structure, the resulting bioelectrode will have even better electrical conductivity and biocompatibility.
[0022] In the present invention, the repeating unit a preferably has one or more repeating units selected from the repeating units A5 to A7 represented by the following general formula (4). [ka] (In general formula (4), R 8 , R 10 , R 12 , R 14 , R16 , and R 18 are each independently a single bond or a linear or branched alkylene group having 1 to 6 carbon atoms. 9 , R 13 , and R 17 are each independently a hydrogen atom, a hydroxyl group, or a linear or branched alkyl group or alkoxy group having 1 to 6 carbon atoms. 11 , R 19 represents a single bond or a linear, branched or cyclic hydrocarbylene group having 1 to 20 carbon atoms, which may have one or more groups selected from a carbonyl group, an ether group and an ester group; R 8 , R 16 R may be bonded to form a ring. 15 is a single bond, or a linear, branched, or cyclic hydrocarbylene group having 1 to 20 carbon atoms, and may have one or more selected from a carbonyl group, an ether group, and an ester group. Rf1 and Rf2 are a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group, and when Rf1 and Rf2 are oxygen atoms, Rf1 and Rf2 are one oxygen atom bonding to one carbon atom to form a carbonyl group, Rf3 and Rf4 are a hydrogen atom, a fluorine atom, or a trifluoromethyl group, and at least one of Rf1 to Rf4 is a fluorine atom or a trifluoromethyl group. Rf5 is a fluorine atom, or a linear or branched alkyl group having 1 to 4 carbon atoms, and has at least one fluorine atom. Rf7 is a linear, branched or cyclic alkyl group having 1 to 10 carbon atoms which may be substituted with a fluorine atom, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms, and has at least one fluorine atom. m is an integer of 1 to 4. a5, a6 and a7 are each 0≦a5≦1.0, 0≦a6≦1.0 and 0≦a7≦1.0, and 0 is an integer of 1 to 4. <a5+a6+a7≦1.0である。M + is an ion selected from an ammonium ion, a sodium ion, a potassium ion, and a silver ion; p is 0 or 1, and q is 1 or 2.
[0023] If the repeating unit a has such a structure, the resulting bioelectrode will have even better electrical conductivity and biocompatibility.
[0024] In the present invention, the repeating unit a preferably contains an ammonium ion represented by the following general formula (3) as an ammonium ion constituting the ammonium salt. [ka] (In general formula (3), R 101d , R 101e , R 101f and R 101g R is a hydrogen atom, a linear, branched, or cyclic alkyl group having 1 to 15 carbon atoms, a linear, branched, or cyclic alkenyl group or alkynyl group having 2 to 12 carbon atoms, or an aromatic group having 4 to 20 carbon atoms, and may have one or more groups selected from an ether group, a carbonyl group, an ester group, a hydroxyl group, a carboxyl group, an amino group, a nitro group, a sulfonyl group, a sulfinyl group, a halogen atom, and a sulfur atom. 101d and R 101e , or R 101d , R 101e and R 101f may form a ring together with the nitrogen atom to which they are attached, and when they form a ring, R 101d and R 101e , or R 101d , R 101e and R 101f is an alkylene group having 3 to 10 carbon atoms, or forms a heteroaromatic ring having the nitrogen atom in the general formula (3) in the ring.
[0025] If the component (A) containing such ammonium ions is included, the resulting bioelectrode will have even better electrical conductivity and biocompatibility.
[0026] In the present invention, the component (B) contained in the material of the living body contact layer preferably contains a resin other than the component (A).
[0027] By including such a component (B), the component (B) is compatible with the component (A), preventing the elution of salt and enabling adhesion to the substrate to be maintained.
[0028] In this case, the component (B) is preferably at least one selected from a silicone resin, a (meth)acrylate resin, and a urethane resin.
[0029] Such a component (B) can further improve the adhesiveness.
[0030] The present invention also provides a method for producing the bioelectrode described above, in which the micropillars are produced by inserting a resin containing the (A) component into a mold that serves as a template, and peeling the resin from the mold.
[0031] Furthermore, the present invention provides a method for producing the above-described bioelectrode, in which the micropillars are produced by inserting a resin containing the (A) component into a resin pattern that serves as a template, and dissolving the resin pattern with water or an alkaline aqueous solution to peel it off.
[0032] With this manufacturing method for bioelectrodes, it is possible to manufacture thin, highly transparent bioelectrodes that have good adhesion to the living body, high sensitivity to biosignals, excellent biocompatibility, are lightweight, and are low-cost, and the sensitivity of the biosignals does not decrease significantly even when wet or dry, or when attached to the skin for long periods of time, making it possible to manufacture comfortable bioelectrodes that do not cause itching, red spots, or rashes on the skin. Effect of the Invention
[0033] As described above, the bioelectrode and the method for manufacturing a bioelectrode of the present invention can provide a bioelectrode and a method for manufacturing a bioelectrode that have good adhesion to a living body, high sensitivity to biosignals, excellent biocompatibility, are thin, lightweight, highly transparent, and can be manufactured at low cost, and that do not significantly reduce the sensitivity of biosignals even when wet or dry, or when attached to the skin for a long period of time, and are comfortable to use and do not cause itching, redness, or rashes on the skin. [Brief description of the drawings]
[0034] [Figure 1] FIG. 2 is a cross-sectional view of a mold for manufacturing the bioelectrode of the present invention. [Diagram 2] 2 is a cross-sectional view of the bioelectrode of the present invention after a biocontact layer is formed on a conductive layer. FIG. [Diagram 3] 1 is a cross-sectional view of the bioelectrode of the present invention when a mold is pressed against the biocontact layer. FIG. [Figure 4] 1 is a cross-sectional structure of a bioelectrode of the present invention in which micropillars are formed after the mold is peeled off. [Diagram 5] FIG. 2 is a cross-sectional view of a mold for producing the bioelectrode of the present invention. [Figure 6] FIG. 2 is an example of a cross-sectional view of a mold pressed against a biological contact layer of the biological electrode of the present invention. [Figure 7] 1 is an example of a cross-sectional structure of a bioelectrode of the present invention in which micropillars are formed after the mold is peeled off. [Figure 8] FIG. 1 is a cross-sectional view of the substrate when it is rolled and peeled off from the mold. [Figure 9] 1 is a cross-sectional view of the bioelectrode of the present invention when it is attached to the skin and a biosignal is being measured. [Figure 10] FIG. 2 is a plan view of a mold for manufacturing the bioelectrode of the present invention. [Figure 11] 11 is another example of a plan view of a mold for manufacturing the bioelectrode of the present invention. FIG. [Figure 12] FIG. 2 is a cross-sectional view of a mold for producing the bioelectrode of the present invention. [Figure 13] 1 is an example of a cross-sectional structure of a bioelectrode of the present invention in which micropillars are formed after the mold is peeled off. [Figure 14] FIG. 2 is a cross-sectional view of a mold for producing the bioelectrode of the present invention. [Figure 15] 1 is an example of a cross-sectional structure of a bioelectrode of the present invention in which micropillars are formed after the mold is peeled off. [Figure 16]FIG. 2 is a cross-sectional view of a mold for producing the bioelectrode of the present invention. [Figure 17] 1 is an example of a cross-sectional structure of a bioelectrode of the present invention in which micropillars are formed after the mold is peeled off. [Figure 18] FIG. 2 is a cross-sectional view of a mold for producing the bioelectrode of the present invention. [Figure 19] FIG. 2 is an example of a cross-sectional view of a mold pressed against an ionic polymer layer of a bioelectrode of the present invention. [Figure 20] 1 is an example of a cross-sectional structure of a bioelectrode of the present invention in which micropillars are formed after the mold is peeled off. [Figure 21] FIG. 2 is a cross-sectional view of a mold for producing the bioelectrode of the present invention. [Figure 22] FIG. 2 is an example of a cross-sectional view of a mold pressed against an ionic polymer layer of a bioelectrode of the present invention. [Diagram 23] 1 is an example of a cross-sectional structure of a bioelectrode of the present invention in which micropillars are formed after the mold is peeled off. [Figure 24] 1 shows a cross-sectional structure after a dissolving layer is formed on a substrate and a resist layer is formed thereon. [Diagram 25] 1 shows a cross-sectional structure of a resist layer and a dissolved layer after exposure and development. [Figure 26] 1 is a cross-sectional structure after a biological contact layer is formed on the pattern of the resist layer and the dissolving layer. [Figure 27] This is a cross-sectional structure after a base material having a conductive layer formed thereon is adhered to a biological contact layer and the base material is peeled off. [Figure 28] This is the cross-sectional structure after the resist layer and dissolvable layer patterns are peeled off and the substrate is turned upside down. [Figure 29] 1 shows a cross-sectional structure of a substrate having a conductive pillar formed on a conductive layer. [Diagram 30] FIG. 1 is a cross-sectional view of a substrate turned upside down, with the conductive layer and conductive pillars immersed in a solution containing an ionic polymer. [Diagram 31] FIG. 13 is a cross-sectional view of a substrate being moved above the ionic polymer-containing solution and then dried. [Diagram 32]FIG. 2 is a plan view after printing a conductive layer onto the substrate. [Diagram 33] FIG. 13 is a plan view of the conductive layer after printing the biological contact layer on the conductive layer. [Diagram 34] FIG. 2 is a plan view of the biological contact layer after micropillars are formed. [Diagram 35] FIG. 2 is a diagram showing the position where the bioelectrode of the present invention is attached when acquiring a biosignal. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0035] As described above, there was a need for the development of a lightweight, thin-film bioelectrode that has excellent conductivity and biocompatibility for generating highly sensitive and low-noise biosignals, is highly transparent, is a highly thin film, can be manufactured at low cost, can measure biosignals whether wet or dry, does not cause skin irritation or itching even when attached to the skin for a long period of time, remains adhesive even when attached to the skin and removed repeatedly, does not lose its adhesiveness even when attached for a long period of time, allows the skin to breathe even when attached for a long period of time, is comfortable and does not become stuffy even when sweating, a method for manufacturing the same, and a method for measuring biosignals.
[0036] Geckos can climb up and down on smooth, slippery, vertical window glass. Geckos' feet are not attached to the window glass by suction or adhesion, but as shown in the above-mentioned Non-Patent Document 2, the soles of their feet have countless tiny spoon-shaped cilia at the tips, and the weight is supported by the van der Waals force between these and the glass surface.
[0037] The force perpendicular to the window glass is weak, so when peeling it off, the feet are pulled vertically. Because the force in the horizontal direction is strong, it will not fall off a vertical window glass where the load is horizontal. Strong adhesive tape requires a lot of force to peel off, but with gecko feet, it can be peeled off easily with relatively little force by simply changing the direction of peeling.
[0038] In bioelectrode applications where electrodes are attached to and removed from the skin, strong adhesive bioelectrodes require a strong force when peeling off, which causes pain to the skin when peeled off. On the other hand, strong adhesive properties are required when electrodes are attached to the skin continuously for long periods of time. The adhesive mechanism using gecko feet is effective in overcoming the trade-off relationship between strong adhesion and easy peeling.
[0039] Sodium, potassium, and calcium ions are released from the skin surface in tandem with the heartbeat. The bioelectrode must convert the increase or decrease in the ions released from the skin into an electrical signal. To do this, a material with excellent ionic conductivity is required to transmit the increase or decrease in ions. The electrical potential of the skin surface also fluctuates in tandem with the heartbeat. This potential fluctuation is slight, so electronic conductivity is also required to transmit a weak current to the device.
[0040] Hydrophilic gels containing sodium chloride or potassium chloride have high ionic conductivity, but lose their conductivity when the water dries up. The conductivity also decreases when sodium chloride or potassium chloride dissolves out of the bioelectrode during bathing or showering.
[0041] Bioelectrodes using metals such as gold and silver detect only weak currents and have low ionic conductivity, making them less sensitive as bioelectrodes. Carbon has electronic conductivity like metals, but it has lower electronic conductivity than metals, making it less sensitive as a bioelectrode.
[0042] The gecko-foot shaped bioelectrode containing conductive filler described in Non-Patent Document 3 has adhesive strength but has low sensitivity as a bioelectrode.
[0043] Fluorosulfonic acid, fluorosulfonimide, and fluorosulfonamide have high polarizability and high ionic conductivity. By combining these polymers with a conductive filler, it is possible to achieve both high ionic conductivity and high electronic conductivity.
[0044] A gecko foot-shaped bioelectrode containing a polymer having one or more selected from fluorosulfonic acid, fluorosulfonimide, and fluorosulfonamide can obtain both sufficient adhesive strength and high sensitivity as a bioelectrode.
[0045] As a result of intensive research into the above-mentioned problems, the present inventors have discovered a bioelectrode having the following configuration and a method for manufacturing a bioelectrode, and have completed the present invention.
[0046] That is, the present invention provides a bioelectrode including a biocontact layer and a substrate, The biological contact layer has micropillars having a diameter of 0.01 to 500 μm and a height of 0.1 to 1,000 μm, and contains an ionic polymer (A) as a material; The component (A) in the bioelectrode contains one or more repeating units a selected from fluorosulfonic acid, fluorosulfonimide, and fluorosulfonamide, and has a weight average molecular weight in the range of 1,000 to 500,000.
[0047] The present invention will be described in detail below, but the present invention is not limited thereto.
[0048] <Bioelectrode> The bioelectrode of the present invention is a bioelectrode including a biocontact layer and a substrate, The biological contact layer has micropillars having a diameter of 0.01 to 500 μm and a height of 0.1 to 1,000 μm, and contains an ionic polymer (A) as a material; The component (A) in the bioelectrode contains one or more repeating units a selected from fluorosulfonic acid, fluorosulfonimide, and fluorosulfonamide, and has a weight average molecular weight in the range of 1,000 to 500,000.
[0049] The diameter of the micropillars is in the range of 0.01 to 500 μm, preferably in the range of 0.05 to 300 μm, and more preferably in the range of 0.08 to 200 μm, and the height of the micropillars is in the range of 0.1 to 1,000 μm, preferably in the range of 0.2 to 800 μm, and more preferably in the range of 0.3 to 500 μm.
[0050] The bioelectrode of the present invention can measure not only electrocardiograms, but also electromyograms, brain waves, and respiratory rates. In addition to measuring signals emitted from the skin, it can also transmit signals to muscles and control brain waves by applying electrical signals to the skin. For example, it can be used to stimulate muscles during swimming to improve performance and reduce fatigue, or to enhance relaxation during bathing.
[0051] A brief explanation will be given with reference to the drawings. A cross section of an example of the bioelectrode of the present invention is shown in Fig. 4. The bioelectrode 10 of the present invention has a biocontact layer 2-1, a conductive layer 3, and a substrate 4, for example.
[0052] 1 to 4 show a method for manufacturing a micropillar-type bioelectrode using a mold. In the cross-sectional view of the mold 1 in FIG. 1, the tip is tapered. In FIG. 2, a cross-sectional view is shown in which a conductive layer 3 is formed on a substrate 4, and a biocontact layer 2 is formed on the conductive layer 3. In FIG. 3, a cross-sectional view is shown in which a mold is pressed against the biocontact layer. The biocontact layer has a functional group that crosslinks with a radical, acid, or base, and may be cured by light irradiation or heating. It may also be a thermoplastic biocontact layer. At this time, the substrate or mold may be heated to soften the ionic polymer and accelerate its penetration into the mold. In the case of a photocurable biocontact layer, the mold needs to be transparent.
[0053] This can be done in a reduced pressure environment to prevent gaps from forming between the micropillars and the mold. When the mold is peeled off, the bioelectrode 10 with the micropillar structure shown in Figure 4 is completed. To facilitate smooth peeling from the mold, a release agent may be applied to the mold in advance. Silicone or fluorine-based materials can be used as the release agent.
[0054] The micropillars shown in Fig. 4 have sharp tips and a small contact area with the skin, which may reduce the sensitivity of the biosignals. To increase the contact area with the skin, for example, a mold 1 shown in Fig. 5 is used and pressure-bonded to the biocontact layer as shown in Fig. 6, resulting in a bioelectrode 10 having a biocontact layer 2-1 with mushroom-shaped micropillars with a large contact area with the skin surface, a conductive layer 3, and a substrate 4 as shown in Fig. 7.
[0055] As shown in FIG. 8, when the substrate 4 is curved, the openings of the micropillars become wider, making them easier to peel off.
[0056] Figure 9 shows a cross-sectional view of a bioelectrode in contact with skin 8 to collect biosignals. The conductive layer 3 is electrically connected to a device for analyzing the biosignals. The gaps between the micropillars allow the skin to breathe, and even if you sweat, the micropillars absorb it, so there is no gap between the bioelectrode and the skin.
[0057] Figure 10 shows a plan view of the mold. The black parts are recesses into which the biocontact layer is inserted to form micropillars. In Figure 10, the hole layout is vertical and horizontal, while in Figure 11 it is diagonal. Figure 11 has a larger number of holes per unit area, making it possible to form high-density micropillars. The arrangement of the micropillars does not have to be regular as shown in Figures 10 and 11.
[0058] In Fig. 12, both sides of the mold 1 are tapered. In this case, it is possible to form a bioelectrode 10 having a biocontact layer 2-1 with mushroom-shaped micropillars, a conductive layer 3, and a substrate 4, as shown in Fig. 13. When peeling off the mold, stress is likely to be applied to the tips of the micropillars, but by peeling off using the method shown in Fig. 8, the stress during peeling can be reduced.
[0059] The mold 1 shown in Fig. 14 has the advantage that the tip is sharp and can be easily inserted into the biocontact layer, and the stress when peeling off the mold is low. In this case, it is possible to form a bioelectrode 10 having a biocontact layer 2-1 with micropillars, a conductive layer 3, and a substrate 4 as shown in Fig. 15.
[0060] The mold 1 shown in Fig. 16 has an asymmetric shape as well as a sharp tip, which has the advantage that the stress in the micropillars is dispersed and reduced when the mold is peeled off, making it easier to peel off. In this case, it is possible to form a bioelectrode 10 having a biocontact layer 2-1 with micropillars, a conductive layer 3, and a substrate 4 as shown in Fig. 17.
[0061] In the mold 1 shown in Fig. 18, the mold deforms when compressed onto the biocontact layer in Fig. 19, and returns to its original shape when peeled off, improving peelability. A soft metal or structure capable of being deformed under stress can be used. In this case, it is possible to form a bioelectrode 10 having a biocontact layer 2-1 with micropillars, a conductive layer 3, and a substrate 4 as shown in Fig. 20.
[0062] In the mold 1 shown in Fig. 21, compressed air is sent to the tip of the mold to deform the tip when compressing it into the biocontact layer of Fig. 22. When peeling, the air pressure is lowered to return it to its original shape, making peeling easier. In this case, it is possible to form a bioelectrode 10 having a biocontact layer 2-1 with micropillars, a conductive layer 3, and a substrate 4 as shown in Fig. 23.
[0063] Figures 24 to 28 show the formation of micropillars by lithography. In Figure 24, a dissolving layer 6 and a resist layer 5 are formed on a substrate 7. The dissolving layer 6 is a material that is not photosensitive but has a higher solubility in a developer than the resist layer 5. A resist is applied onto the dissolving layer 6. Since it is necessary not to mix the resist layer 5 and the dissolving layer 6, it is preferable that the dissolving layer 6 is an aqueous solution and the resist layer 5 is an organic solvent-based material. A chemically amplified resist can be used for the resist layer 5. After exposure, the substrate is baked (PEB) and developed. An alkaline aqueous solution can be used as the developer. A cross-sectional view of the pattern after development is shown in Figure 25. The dissolving layer 6 dissolves faster in the developer than the resist layer 5, resulting in an undercut shape.
[0064] When the entire surface of the developed pattern in Fig. 25 is exposed to light and PEB is performed, the polarity of the resist layer changes to hydrophilicity and becomes less soluble in organic solvents. This allows the resist pattern to be retained without dissolving when the ionic polymer-containing solution in Fig. 26 is applied thereon to form the biological contact layer 2-1.
[0065] An ionic polymer solution is applied and baked, and then the substrate is peeled off, or before the substrate is peeled off, a base material 4 coated with a conductive layer 3 as shown in Figure 27 is attached, and the resist layer and dissolving layer patterns are peeled off, to form a bioelectrode 10 having a biocontact layer 2-1 having micropillars, a conductive layer 3, and a base material 4 as shown in Figure 28.
[0066] Figures 29 to 31 show a method for coating a biocontact layer on a substrate on which a conductive layer of conductive pillars has been formed. The conductive pillars 3-1 on the conductive layer 3 coated on the substrate 4 shown in Figure 29 are immersed in an ionic polymer-containing solution 2-2 as shown in Figure 30, and then pulled out and dried as shown in Figure 31 to form a biocontact layer 2-1.
[0067] <Materials for the biological contact layer> Each component constituting the biocontact layer of the bioelectrode of the present invention will be described in more detail below.
[0068] [(A) Ionic polymer (salt)] The ionic polymer (A) used in the bioelectrode of the present invention contains one or more repeating units a selected from fluorosulfonic acid, fluorosulfonimide, and fluorosulfonamide, and has a weight average molecular weight in the range of 1,000 to 500,000. The ionic material (A) may contain a polymer having an ionic repeating unit selected from the ammonium salt, sodium salt, potassium salt, and silver salt of any of fluorosulfonic acid, fluorosulfonimide, and N-carbonylfluorosulfonamide.
[0069] (Repeating unit a) The repeating unit a can have a partial structure represented by the following general formulas (1)-1 to (1)-4. [ka] (In the formula, Rf1 and Rf2 are a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group. When Rf1 and Rf2 are oxygen atoms, Rf1 and Rf2 are one oxygen atom bonding to one carbon atom to form a carbonyl group. Rf3 and Rf4 are a hydrogen atom, a fluorine atom, or a trifluoromethyl group. One or more of Rf1 to Rf4 are a fluorine atom or a trifluoromethyl group. Rf5 is a fluorine atom, or a linear or branched alkyl group having 1 to 4 carbon atoms and has at least one fluorine atom. Rf6 and Rf7 are a linear, branched, or cyclic alkyl group having 1 to 10 carbon atoms which may be substituted with a fluorine atom, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms and has at least one fluorine atom. M + is an ion selected from an ammonium ion, a sodium ion, a potassium ion, and a silver ion; and m is an integer of 1 to 4.
[0070] The repeating unit a preferably has one or more repeating units selected from the repeating units A1 to A4 represented by the following general formula (2). [ka] (In general formula (2), R 1 , R 3 , R 4 , and R 6 are each independently a hydrogen atom or a methyl group, R 2 , R 5 , and R 7 are each independently a single bond, or a linear, branched or cyclic hydrocarbon group having 1 to 13 carbon atoms, and may have an ester group, an ether group, or both. X1, X2, X3, and X4 are each independently a single bond, a phenylene group, a naphthylene group, an ether group, an ester group, or an amide group. Rf1 and Rf2 are a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group, and when Rf1 and Rf2 are oxygen atoms, Rf1 and Rf2 are an oxygen atom that bonds to one carbon atom to form a carbonyl group, and Rf3 and Rf4 are a hydrogen atom, a fluorine atom, or a trifluoromethyl group, and at least one of Rf1 to Rf4 is a fluorine atom or a trifluoromethyl group. Rf5 is a fluorine atom, or a linear or branched alkyl group having 1 to 4 carbon atoms, and has at least one fluorine atom. Rf6 and Rf7 are a linear, branched or cyclic alkyl group having 1 to 10 carbon atoms, which may be substituted with a fluorine atom, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms, and have at least one fluorine atom. m is an integer of 1 to 4. a1, a2, a3 and a4 are each 0≦a1≦1.0, 0≦a2≦1.0, 0≦a3≦1.0 and 0≦a4≦1.0, and 0≦a1≦1.0 is an integer of 1 to 4. <a1+a2+a3+a4≦1.0である。M + is an ion selected from ammonium ion, sodium ion, potassium ion, and silver ion.
[0071] In the above general formula (2), a1 to a4 represent the ratios of the repeating units A1 to A4, respectively.
[0072] The repeating unit a preferably has one or more repeating units selected from the repeating units A5 to A7 represented by the following general formula (4). [ka] (In general formula (4), R 8 , R 10 , R 12 , R 14 , R 16 , and R 18 are each independently a single bond or a linear or branched alkylene group having 1 to 6 carbon atoms. 9 , R 13 , and R 17 are each independently a hydrogen atom, a hydroxyl group, or a linear or branched alkyl group or alkoxy group having 1 to 6 carbon atoms. 11 , R 19 represents a single bond or a linear, branched or cyclic hydrocarbylene group having 1 to 20 carbon atoms, which may have one or more groups selected from a carbonyl group, an ether group and an ester group; R 8 , R 16 R may be bonded to form a ring. 15is a single bond, or a linear, branched, or cyclic hydrocarbylene group having 1 to 20 carbon atoms, and may have one or more selected from a carbonyl group, an ether group, and an ester group. Rf1 and Rf2 are a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group, and when Rf1 and Rf2 are oxygen atoms, Rf1 and Rf2 are one oxygen atom bonding to one carbon atom to form a carbonyl group, Rf3 and Rf4 are a hydrogen atom, a fluorine atom, or a trifluoromethyl group, and at least one of Rf1 to Rf4 is a fluorine atom or a trifluoromethyl group. Rf5 is a fluorine atom, or a linear or branched alkyl group having 1 to 4 carbon atoms, and has at least one fluorine atom. Rf7 is a linear, branched or cyclic alkyl group having 1 to 10 carbon atoms which may be substituted with a fluorine atom, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms, and has at least one fluorine atom. m is an integer of 1 to 4. a5, a6 and a7 are each 0≦a5≦1.0, 0≦a6≦1.0 and 0≦a7≦1.0, and 0 is an integer of 1 to 4. <a5+a6+a7≦1.0である。M + is an ion selected from an ammonium ion, a sodium ion, a potassium ion, and a silver ion; p is 0 or 1, and q is 1 or 2.
[0073] In the above general formula (4), a5 to a7 represent the ratios of repeating units A5 to A7, respectively.
[0074] (Repeating units A1 to A4) Of the repeating units A1 to A4 represented by the above general formula (2), specific examples of the fluorosulfonate monomer for obtaining the repeating units A1 and A2 are shown below.
[0075] [ka]
[0076] [ka]
[0077]
change
[0078]
change
[0079]
change
[0080]
change
[0081]
change
[0082]
change
[0083]
change
[0084]
change
[0085]
change
[0086]
change
[0087]
change
[0088]
change
[0089]
change
[0090]
change
[0091]
change
[0092]
change
[0093]
change
[0094]
change
[0095]
change
[0096]
change
[0097]
change
[0098] [ka]
[0099] Specific examples of the sulfonimide salt monomer for obtaining the repeating unit A3 represented by the above general formula (2) include those shown below.
[0100] [ka]
[0101] [ka]
[0102] [ka]
[0103] [ka]
[0104] [ka]
[0105] Specific examples of the N-carbonylsulfonamide salt monomer for obtaining the repeating unit A4 represented by the above general formula (2) include those shown below. [ka]
[0106] [ka]
[0107] [ka]
[0108] [ka]
[0109] [ka] (In the formula, R 1 , R 3 , R 4 , R 6 As mentioned above.)
[0110] (Repeating unit b) In addition to the repeating units A1 to A4, the component (A) may also be copolymerized with a repeating unit b having a glyme chain in order to improve ionic conductivity. Specific examples of monomers for obtaining the repeating unit b having a glyme chain include those shown below. By copolymerizing a repeating unit having a glyme chain, the movement of ions released from the skin in the dry electrode film can be promoted, and the sensitivity of the dry electrode can be increased.
[0111] [ka]
[0112] [ka]
[0113] [ka]
[0114] [ka] (In the formula, R is a hydrogen atom or a methyl group.)
[0115] (Repeating unit c) In addition to the repeating units A1 to A4 and b, the component (A) may also be copolymerized with a hydrophilic repeating unit c having a hydroxyl group, a carboxyl group, an ammonium salt, a betaine, an amide group, a pyrrolidone, a lactone ring, a lactam ring, a sultone ring, a sulfonic acid, a sodium salt of sulfonic acid, or a potassium salt of sulfonic acid, in order to improve electrical conductivity. Specific examples of monomers for obtaining the hydrophilic repeating unit c include those listed below. By copolymerizing repeating units containing these hydrophilic groups, it is possible to increase the sensitivity of the ions released from the skin and increase the sensitivity of the dry electrode.
[0116] [ka]
[0117] [ka]
[0118] [ka] (In the formula, R is a hydrogen atom or a methyl group.)
[0119] (Repeating unit d) The component (A) may contain a fluorine-containing repeating unit d in addition to the repeating units A1 to A4, b and c described above.
[0120] Specific examples of monomers for obtaining the fluorine-containing repeating unit d include the following.
[0121] [ka]
[0122] [ka]
[0123] [ka]
[0124] [ka]
[0125] [ka]
[0126] [ka] (In the formula, R is a hydrogen atom or a methyl group.)
[0127] (Repeating unit e) The component (A) may further contain a repeating unit e having a nitro group, in addition to the repeating units A1 to A4, b, c and d described above.
[0128] Specific examples of monomers from which the repeating unit e having a nitro group can be obtained include the following.
[0129] [ka]
[0130] [ka]
[0131] [ka]
[0132] [ka]
[0133] [ka]
[0134] [ka] (In the formula, R is a hydrogen atom or a methyl group.)
[0135] (Repeating unit f) The component (A) may further contain a repeating unit f having a cyano group, in addition to the repeating units A1 to A4, b, c, d and e described above.
[0136] Specific examples of monomers from which the repeating unit f having a cyano group is obtained include the following.
[0137] [ka]
[0138] [ka]
[0139] [ka] (In the formula, R is a hydrogen atom or a methyl group.)
[0140] (Repeating unit g) The component (A) may further contain a repeating unit g having an oxirane group or an oxetane group, in addition to the repeating units A1 to A4, b, c, d, e and f described above.
[0141] Specific examples of monomers from which the repeating unit g having an oxirane group or oxetane group is derived include the following. [ka]
[0142] [ka] (In the formula, R is a hydrogen atom or a methyl group.)
[0143] (Repeating unit h) The component (A) may further include a repeating unit h having an isocyanate group or a blocked isocyanate group, in addition to the repeating units A1 to A4, b, c, d, e, f and g described above.
[0144] Specific examples of monomers for obtaining the repeating unit h having an isocyanate group or a blocked isocyanate group include the following. [ka] (In the formula, R is a hydrogen atom or a methyl group.)
[0145] As a method for synthesizing the ionic polymer (A) containing the repeating units A1 to A4 described in general formula (2), for example, a desired monomer among the monomers which give the repeating units A1 to A4, b, c, d, e, f, g, and h described above is added to a radical polymerization initiator in an organic solvent and heat-polymerized to obtain the ionic polymer (A).
[0146] Examples of the organic solvent used during polymerization include toluene, benzene, tetrahydrofuran, diethyl ether, dioxane, cyclohexane, cyclopentane, methyl ethyl ketone, and γ-butyrolactone.
[0147] Examples of the radical polymerization initiator include 2,2'-azobisisobutyronitrile (AIBN), 2,2'-azobis(2,4-dimethylvaleronitrile), dimethyl 2,2'-azobis(2-methylpropionate), benzoyl peroxide, and lauroyl peroxide.
[0148] The reaction temperature is preferably 50 to 80° C., and the reaction time is preferably 2 to 100 hours, more preferably 5 to 20 hours.
[0149] In the ionic polymer (A), the monomers giving the repeating units A1 to A4 may be of one type or of two or more types. When two or more kinds of monomers giving the repeating units A1 to A4 are used, the respective monomers may be copolymerized randomly or in blocks.
[0150] The monomers giving the repeating units A1 to A4, b, c, d, e, f, g and h may be copolymerized randomly, or each may be copolymerized in a block.
[0151] When random copolymerization is performed by radical polymerization, the monomers to be copolymerized and a radical polymerization initiator are mixed and polymerized by heating. When polymerization is started in the presence of a first monomer and a radical polymerization initiator, and a second monomer is added later, one side of the polymer molecule has a structure in which the first monomer is polymerized, and the other side has a structure in which the second monomer is polymerized. However, in this case, the repeating units of the first and second monomers are mixed in the middle part, which is different from a block copolymer. Living radical polymerization is preferably used to form a block copolymer by radical polymerization.
[0152] In the living radical polymerization method called RAFT polymerization (Reversible Addition Fragmentation chain Transfer polymerization), the radicals at the polymer end are always alive, so it is possible to form a diblock copolymer consisting of a block of repeating units of the first monomer and a block of repeating units of the second monomer by initiating polymerization with a first monomer and adding a second monomer when the first monomer is consumed. It is also possible to form a triblock polymer by initiating polymerization with a first monomer and adding a second monomer when the first monomer is consumed and then adding a third monomer.
[0153] RAFT polymerization is characterized by the formation of narrow-dispersity polymers with narrow molecular weight distributions (dispersity). In particular, when RAFT polymerization is performed by adding the monomers all at once, polymers with even narrower molecular weight distributions can be formed.
[0154] A chain transfer agent is required to carry out RAFT polymerization, and specific examples thereof include 2-cyano-2-propyl benzothioate, 4-cyano-4-phenylcarbonothioylthiopentanoic acid, 2-cyano-2-propyldodecyltrithiocarbonate, 4-cyano-4-[(dodecylsulfanylthiocarbonyl)sulfanyl]pentanoic acid, 2-(dodecylthiocarbonothioylthio)-2-methylpropanoic acid, cyanomethyldodecylthiocarbonate, cyanomethylmethyl(phenyl)carbamothioate, bis(thiobenzoyl)disulfide, and bis(dodecylsulfanylthiocarbonyl)disulfide. Among these, 2-cyano-2-propyl benzothioate is particularly preferred.
[0155] The ionic polymer has a weight average molecular weight in the range of 1,000 to 500,000, preferably 2,000 to 200,000. If the weight average molecular weight is less than 1,000, the heat resistance will be poor, and there may be residues on the skin after peeling off in contact with the skin. On the other hand, when the weight average molecular weight exceeds 500,000, the viscosity increases, the workability deteriorates, and the solubility in organic solvents decreases.
[0156] Incidentally, the weight average molecular weight (Mw) is a measurement value in terms of polyethylene oxide, polyethylene glycol, or polystyrene by gel permeation chromatography (GPC) using dimethylformamide (DMF) and tetrahydrofuran (THF) as solvents.
[0157] As shown in JP-A-2021-164630, radical-reactive (meth)acrylate groups and styrene groups can also be introduced by reaction with hydroxy groups, carboxy groups, oxirane groups, oxetane groups, isocyanate groups, etc. of the ionic polymer after polymerization.
[0158] Here, the ratios of the repeating units A1 to A4, b, c, d, e, f, g, h in the ionic polymer are 0 ≦ a1 ≦ 1.0, 0 ≦ a2 ≦ 1.0, 0 ≦ a3 ≦ 1.0, 0 ≦ a4 ≦ 1.0, 0 < a1 + a2 + a3 + a4 ≦ 1.0, 0 ≦ b < 1.0, 0 ≦ c < 1.0, 0 ≦ d < 1.0, 0 ≦ e < 1.0, 0 ≦ f < 1.0, 0 ≦ g < 1.0, 0 ≦ h < 1.0, preferably 0 ≦ a1 ≦ 1.0, 0 ≦ a2 ≦ 1.0, 0 ≦ a3 ≦ 1.0, 0 ≦ a4 ≦ 1.0, 0.1 ≦ a1 + a2 + a3 + a4 ≦ 1.0, 0 ≦ b ≦ 0.8, 0 ≦ c ≦ 0.8, 0 ≦ d ≦ 0.8, 0 ≦ e ≦ 0.8, 0 ≦ f ≦ 0.8, 0 ≦ g ≦ 0.8, 0 ≦ h ≦ 0.8, more preferably 0 ≦ a1 ≦ 1.0, 0 ≦ a2 ≦ 1.0, 0 ≦ a3 ≦ 1.0, 0 ≦ a4 ≦ 1.0, 0.2 ≦ a1 + a2 + a3 + a4 ≦ 1.0, 0 ≦ b ≦ 0.7, 0 ≦ c ≦ 0.7, 0 ≦ d ≦ 0.7, 0 ≦ e ≦ 0.7, 0 ≦ f ≦ 0.7, 0 ≦ g ≦ 0.7, 0 ≦ h ≦ 0.7. b, c, d, e, f, g, h are the ratios of the repeating units b to h, respectively.
[0159] (Repeating units A5 to A7) The monomers from which the repeating units A5 to A7 represented by the general formula (4) are obtained have hydroxy groups at both ends, and can be reacted with an isocyanate compound to extend the chain length, thereby forming a high molecular weight polymer.
[0160] The repeating unit A5 or A6 can be obtained by reacting a monomer having a dihydroxy group represented by the following general formula a5-1 or a6-1 with a compound having an isocyanate group. [ka] (In the formula, R 8 ~R 15 , Rf1~Rf5, p, q, m, M + is as above.)
[0161] Specific examples of the dihydroxy group-containing monomer represented by the general formula a5-1 include the following.
[0162] [ka]
[0163] [ka]
[0164] [ka]
[0165] [ka]
[0166] [ka]
[0167] [ka]
[0168] [ka]
[0169] [ka]
[0170] [ka]
[0171] [ka]
[0172] [ka]
[0173] [ka]
[0174] Specific examples of the dihydroxy group-containing monomer represented by the general formula a6-1 include the following.
[0175] [ka]
[0176] The repeating unit A7 can be obtained by reacting a monomer having a dihydroxy group represented by the following general formula a7-1 with a compound having an isocyanate group. [ka] (In the formula, R 16 ~R 19, Rf7, M + is as above.)
[0177] Specific examples of the dihydroxy group-containing monomer represented by the general formula a7-1 include the following.
[0178] [ka]
[0179] [ka]
[0180] [ka]
[0181] [ka]
[0182] [ka]
[0183] [ka]
[0184] [ka]
[0185] [ka]
[0186] [ka]
[0187] [ka]
[0188] [ka]
[0189] The ionic polymer (A) containing the repeating units A5, A6, and A7 represented by the general formula (4) can be obtained by reacting the monomer having a dihydroxy group represented by the general formulas a5-1, a6-1, and a7-1 with a compound having an isocyanate group. The compound having an isocyanate group can be exemplified as follows.
[0190] [ka]
[0191] [ka] (In the formula, t is an integer of 1 or more.)
[0192] The ionic polymer (A) containing the repeating units A5, A6, and A7 represented by the general formula (4) can be obtained by reacting a monomer having a dihydroxy group with a compound having an isocyanate group, but it may also be reacted with a compound having a hydroxy group other than those represented by the general formulae a5-1, a6-1, and a7-1.
[0193] Examples of compounds having a hydroxy group other than those of the above general formulae a5-1, a6-1 and a7-1 include polyether compounds having a diol terminal, as exemplified below.
[0194] [ka]
[0195] [ka] (Here, the brackets are the repeating units.)
[0196] [ka]
[0197] Examples of the diol compound obtained from a polyester compound having a copolymerizable terminal diol as a raw material include those shown below.
[0198] [ka]
[0199] [ka]
[0200] [ka] (Here, the brackets are the repeating units.)
[0201] It can also be copolymerized with the following polycarbonate compound having a diol terminal.
[0202] [ka] (Here, the brackets are the repeating units.)
[0203] Furthermore, it can also be copolymerized with the following diol compounds having a fluoroalkyl group or a fluoroalkylene group.
[0204] [ka] (where m and n are in the range of 0 to 20.)
[0205] [ka] (where m ranges from 1 to 20.)
[0206] [ka]
[0207] [ka]
[0208] [ka]
[0209] [ka]
[0210] [ka]
[0211] [ka] (Here, n and q are in the ranges of 1 to 20, 2≦n+q≦21, and 1≦p≦40.)
[0212] [ka]
[0213] [ka] (where m ranges from 1 to 20.)
[0214] [ka] (where m, r, s, and t are in the range of 0 to 20.)
[0215] Furthermore, it can also be copolymerized with a diol compound having a fluoroalcohol group or a sulfonamide group, as described in JP-A-2022-078861.
[0216] It can also be copolymerized with the silicon-pendant diol compounds described below.
[0217] [ka]
[0218] [ka]
[0219] [ka]
[0220] [ka]
[0221] [ka]
[0222] [ka]
[0223] [ka]
[0224] [ka]
[0225] [ka]
[0226] [ka]
[0227] [ka]
[0228] [ka] (where m, n, and p are in the range of 1 to 20.)
[0229] Among the above isocyanate compounds, in particular, isocyanate compounds having a (meth)acrylate group can be reacted with compounds represented by the general formulae a5-1, a6-1, and a7-1 or other hydroxy compounds to obtain compounds having a (meth)acrylate group at the end. Compounds having a (meth)acrylate group at the end can also be obtained by reacting a hydroxy compound having a (meth)acrylate group with an isocyanate compound.
[0230] Among the above isocyanate compounds, in particular, isocyanate compounds having a maleimide group can be reacted with the compounds represented by the general formulae a5-1, a6-1, and a7-1 or other hydroxy compounds to obtain compounds having a maleimide group at the terminal. Compounds having a maleimide group at the terminal can also be obtained by reacting a hydroxy compound having a maleimide group with an isocyanate compound.
[0231] The above-mentioned isocyanate compounds have high reactivity with hydroxyl group-containing compounds, and it may be difficult to control this. In addition, since the isocyanate compounds may react with moisture in the air during storage and the isocyanate group may be deactivated, sufficient care must be taken during storage, such as preventing humidity. Therefore, in order to prevent these events, a compound having a blocked isocyanate group in which the isocyanate group is protected by a substituent may be used.
[0232] The blocked isocyanate group is a group in which the blocking group is deprotected by heating to become an isocyanate group. Specific examples of the blocked isocyanate group include isocyanate groups substituted with alcohol, phenol, thioalcohol, imine, ketimine, amine, lactam, pyrazole, oxime, β-diketone, etc.
[0233] A catalyst can be added to lower the deprotection temperature of the blocked isocyanate group. Known examples of such catalysts include organotins such as dibutyltin dilaurate, bismuth salts, and zinc carboxylates such as zinc 2-ethylhexanoate and zinc acetate.
[0234] In particular, JP 2012-152725 A discloses that the deprotection reaction can be carried out at a lower temperature by using an α,β-unsaturated carboxylate zinc salt as a carboxylic acid and a blocked isocyanate dissociation catalyst.
[0235] Moreover, the repeating unit a preferably contains, as the ammonium ion constituting the ammonium salt, an ammonium ion (ammonium cation) represented by the following general formula (3). [ka] (In general formula (3), R 101d , R 101e , R 101f and R 101gR is a hydrogen atom, a linear, branched, or cyclic alkyl group having 1 to 15 carbon atoms, a linear, branched, or cyclic alkenyl group or alkynyl group having 2 to 12 carbon atoms, or an aromatic group having 4 to 20 carbon atoms, and may have one or more groups selected from an ether group, a carbonyl group, an ester group, a hydroxyl group, a carboxyl group, an amino group, a nitro group, a sulfonyl group, a sulfinyl group, a halogen atom, and a sulfur atom. 101d and R 101e , or R 101d , R 101e and R 101f may form a ring together with the nitrogen atom to which they are attached, and when they form a ring, R 101d and R 101e , or R 101d , R 101e and R 101f is an alkylene group having 3 to 10 carbon atoms, or forms a heteroaromatic ring having the nitrogen atom in the general formula (3) in the ring.
[0236] Specific examples of the ammonium ion represented by the above general formula (3) include the following.
[0237] [ka]
[0238] [ka]
[0239] [ka]
[0240] [ka]
[0241] [ka]
[0242]
change
[0243]
change
[0244]
change
[0245]
change
[0246]
change
[0247]
change
[0248]
change
[0249]
change
[0250]
change
[0251]
change
[0252]
change
[0253] [ka]
[0254] [ka]
[0255] [ka]
[0256] [ka]
[0257] [ka]
[0258] [Other ingredients] (Surfactant) A surfactant may be added to the material for forming the biocontact layer included in the bioelectrode of the present invention in order to increase wettability to a workpiece such as a substrate such as a mold or a conductive layer. Examples of such surfactants include various nonionic, cationic, and anionic surfactants. Specific examples include nonionic surfactants such as polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene carboxylate, sorbitan ester, and polyoxyethylene sorbitan ester; cationic surfactants such as alkyl trimethyl ammonium chloride and alkyl benzyl ammonium chloride; anionic surfactants such as alkyl or alkyl aryl sulfate, alkyl or alkyl aryl sulfonate, and dialkyl sulfosuccinate; and amphoteric surfactants such as amino acid type and betaine type. The amount of surfactant to be added is preferably 0.01 to 0.1 parts by mass relative to 100 parts by mass of the ionic polymer (A).
[0259] [(B) Resin] The material of the biocontact layer may contain a resin other than the component (A) as the component (B). The resin (B) is a component for preventing the elution of the ionic polymer (A) and for maintaining adhesion to the substrate. The component (B) is preferably one or more resins selected from silicone resins, (meth)acrylate resins, and urethane resins. The amount of the component (B) is preferably 1 to 10,000 parts by mass per 100 parts by mass of the ionic polymer (A).
[0260] [Optional ingredients] The material for forming the biocontact layer contained in the bioelectrode of the present invention may contain optional components such as an ionic additive and an organic solvent.
[0261] [Ionic additives] An ionic additive for increasing ionic conductivity can be added to the material for forming the biocontact layer contained in the bioelectrode of the present invention. In consideration of biocompatibility, sodium chloride, potassium chloride, calcium chloride, saccharin, acesulfame potassium, and salts described in JP-A-2018-044147, JP-A-2018-059050, JP-A-2018-059052, and JP-A-2018-130534 can be mentioned. The amount of the ionic additive is preferably 0.1 to 100 parts by mass per 100 parts by mass of (A) ionic polymer.
[0262] Ammonium salts of fluorosulfonic acid, fluoroimidic acid, and fluoromethic acid are known as ionic liquids. Specifically, the ionic liquids described in the following literature can be added. Trulove C, Mantz R. 2003. Ionic Liquids in Synthesis, Chapter 3.6: Electrochemical Properties of Ionic Liquids.
[0263] [Silicone compounds having polyglycerin structure] In the material for forming the biocontact layer included in the bioelectrode of the present invention, a silicone compound having a polyglycerin structure can be added in order to improve the moisture retention of the film and improve the sensitivity and ion conductivity of ions released from the skin. The amount of the silicone compound having a polyglycerin structure is preferably 0.01 to 100 parts by mass, more preferably 0.5 to 60 parts by mass, per 100 parts by mass of the total of the (A) component and the (B) component. The silicone compound having a polyglycerin structure may be used alone or in a mixture of two or more types.
[0264] Examples of silicone compounds having a polyglycerin structure include those described in JP-A-2021-115458.
[0265] A material containing a silicone compound having such a polyglycerin structure can exhibit better moisturizing properties, and as a result, can be used to form a biological contact layer that can exhibit better sensitivity to ions released from the skin.
[0266] [Metal powder] In order to enhance electronic conductivity, a metal powder selected from gold, silver, platinum, copper, tin, titanium, nickel, aluminum, tungsten, molybdenum, ruthenium, chromium, and indium may be added to the material for forming the biocontact layer contained in the bioelectrode of the present invention. The amount of metal powder or carbon added is preferably in the range of 1 to 50 parts by mass per 100 parts by mass of the resin consisting of the combined components (A) and (B).
[0267] As the type of metal powder, gold, silver, and platinum are preferred from the viewpoint of electrical conductivity, and silver, copper, tin, titanium, nickel, aluminum, tungsten, molybdenum, ruthenium, and chromium are preferred from the viewpoint of cost. From the viewpoint of biocompatibility, noble metals are preferred, and from these viewpoints overall, silver is the most preferred.
[0268] The shape of the metal powder can be spherical, disk-like, flake-like, or needle-like, but the addition of flake-like powder is the most conductive and is preferred. The size of the metal powder is 100 μm or less, and the tap density is 5 g / cm. 3 Below, the specific surface area is 0.5m 2 Flakes with a relatively low density and large specific surface area of 100 / g or more are preferred.
[0269] [Carbon materials] A carbon material can be added as a conductivity improver. Examples of the carbon material include carbon black, graphite, carbon nanotubes, carbon fibers, graphene, etc. The carbon nanotubes may be either single-walled or multi-walled, and the surface may be modified with an organic group. The amount of the carbon material added is preferably in the range of 1 to 50 parts by mass per 100 parts by mass of the resin, which is the combined resin of components (A) and (B).
[0270] [Silicon powder] Silicon powder can be added to the material for forming the biocontact layer included in the bioelectrode of the present invention in order to increase the sensitivity of ion reception. Examples of silicon powder include powders made of silicon, silicon monoxide, and silicon carbide. The particle size of the powder is preferably smaller than 100 μm, and more preferably 1 μm or less. Since finer particles have a larger surface area, they can receive more ions, resulting in a highly sensitive bioelectrode. The amount of silicon powder added is preferably in the range of 1 to 50 parts by mass per 100 parts by mass of the resin, which is the combined resin of components (A) and (B).
[0271] [Lithium titanate powder] Lithium titanate powder can be added to the material for forming the biocontact layer included in the bioelectrode of the present invention in order to increase the sensitivity of ion reception. Lithium titanate powder includes Li2TiO3, LiTiO2, and Li4Ti5O with a spinel structure. 12 The molecular formula can be mentioned, and a spinel structure product is preferable. Lithium titanate particles composited with carbon can also be used. The particle size of the lithium titanate powder is preferably smaller than 100 μm, more preferably 1 μm or less. Since finer particles have a larger surface area, they can receive a larger number of ions, resulting in a highly sensitive bioelectrode. These may be composite powders with carbon. The amount of lithium titanate powder added is preferably in the range of 1 to 50 parts by mass per 100 parts by mass of the resin consisting of the (A) component and the (B) component combined.
[0272] [Organic solvents] Specific examples of the organic solvent include ketone-based solvents such as cyclohexanone, cyclopentanone, 2-octanone, 2-nonanone, 2-heptanone, 3-heptanone, 4-heptanone, 2-hexanone, 3-hexanone, diisobutyl ketone, methylcyclohexanone, and methyl n-pentyl ketone; alcohol-based solvents such as 3-methoxybutanol, 3-methyl-3-methoxybutanol, 1-methoxy-2-propanol, and 1-ethoxy-2-propanol; propylene glycol monomethyl ether, ethylene glycol monomethyl ether, propylene glycol monoethyl ether, ethylene glycol monoethyl ether, propylene glycol dimethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monopropyl ether, diethylene glycol monobutyl ether, diethylene glycol monopentyl ether, and diethylene glycol monoheptyl ether; Examples of the solvent include ether solvents such as propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, ethyl lactate, ethyl pyruvate, butyl acetate, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, tert-butyl acetate, tert-butyl propionate, propylene glycol mono-tert-butyl ether acetate, and anisole; ester solvents such as propylene glycol mono-tert-butyl ether acetate, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, tert-butyl acetate, tert-butyl propionate, and propylene glycol mono-tert-butyl ether acetate; and lactone solvents such as γ-butyrolactone.
[0273] The amount of the organic solvent added is preferably within a range of 10 to 50,000 parts by mass per 100 parts by mass of the resin, which is the combined total of the (A) and (B) components.
[0274] When the ionic polymer has an oxirane group or an oxetane group in the repeating unit, an amine-based crosslinking agent or an imidazole-based crosslinking catalyst can be added.
[0275] A (meth)acrylate monomer can be added to reduce the viscosity of a solution containing an ionic polymer or to crosslink the solution. For crosslinking, a monomer containing multiple (meth)acrylates in one molecule is preferred.
[0276] A radical generator can also be added to react with (meth)acrylate. The radical generator is a compound that generates radicals by heat or light, and specifically, those exemplified in JP2020-097214A can be used.
[0277] <Manufacturing method of bioelectrodes> The present invention provides a method for producing the bioelectrode described above, in which the micropillars are produced by inserting a resin containing the (A) component into a mold that serves as a template, and peeling the resin from the mold. The present invention also provides a method for producing the above-described bioelectrode, in which the micropillars are produced by inserting a resin containing the (A) component into a resin pattern that serves as a template, and dissolving the resin pattern with water or an alkaline aqueous solution to peel it off. Furthermore, the present invention provides a method for producing a bioelectrode, which comprises forming a conductive layer on a substrate and forming a biocontact layer having ionic polymer-containing micropillars on the surface of the conductive layer that comes into contact with the skin.
[0278] The substrate is preferably flexible, stretchable, and transparent. Thin-film glass is flexible and highly transparent, but if it breaks while attached to the skin, it will damage the skin, so it is preferable to use a resin that does not break. Examples of resins that can be used as the substrate include poly(meth)acrylate (PMMA), polyurethane, silicone, PEEK, polyimide, polyolefin, styrene butadiene rubber, polycarbonate, PET, PEN, vinyl chloride, polystyrene, polyethylene, polypropylene, polymethylpentene, and Teflon (registered trademark).
[0279] When forming a conductive layer on a substrate, a method of printing a conductive pattern using a conductive paste containing conductive particles, a resin and a solvent, or a method of attaching a thin metal film can be used.
[0280] The method of applying the material for forming the biocontact layer on the conductive layer is not particularly limited, and includes a method of directly applying the material and a method of applying the material onto another substrate and then transferring the material. In either case, methods such as dip coating, spray coating, spin coating, roll coating, flow coating, doctor coating, screen printing, flexographic printing, gravure printing, and inkjet printing are suitable.
[0281] The conductive layer may be formed by the same method as that used for applying the material for forming the biological contact layer.
[0282] After coating the conductive layer or the material for forming the biocontact layer, heating is performed in order to evaporate the solvent and solidify the layer.
[0283] The temperature at which the material for forming the biological contact layer is heated after coating is not particularly limited, and is preferably about 50 to 250°C, for example.
[0284] The method of forming the biocontact layer into micropillars using a mold is shown in Figs.
[0285] A method of forming a pattern to serve as a template using lithography, forming a biological contact layer thereon, and then dissolving and removing the template pattern is shown in FIGS.
[0286] A method for forming a biological contact layer on the surface of a conductive pillar connected to a conductive layer is shown in FIGS.
[0287] After the micropillars are formed, water droplets or water vapor or mist can be sprayed onto the surface of the biocontact layer to improve compatibility with the skin and allow for quick biosignals to be obtained. Water mixed with alcohol can also be used to reduce the size of the water vapor or mist droplets. The layer surface or skin surface can also be moistened by contacting it with absorbent cotton or cloth soaked in water.
[0288] The water that wets the surface of the biocontact layer after the formation of the micropillars may contain a salt. The water-soluble salt that is mixed with the water is preferably selected from sodium salts, potassium salts, calcium salts, magnesium salts, and betaine.
[0289] Specifically, the water-soluble salt may be a salt selected from sodium chloride, potassium chloride, calcium chloride, magnesium chloride, saccharin sodium salt, acesulfame potassium, sodium carboxylate, potassium carboxylate, calcium carboxylate, sodium sulfonate, potassium sulfonate, calcium sulfonate, sodium phosphate, potassium phosphate, calcium phosphate, magnesium phosphate, and betaine. Note that the above-mentioned (A) ionic polymer is not included in the water-soluble salt.
[0290] More specifically, in addition to the above, sodium acetate, sodium propionate, sodium pivalate, sodium glycolate, sodium butyrate, sodium valerate, sodium caproate, sodium enanthate, sodium caprylate, sodium pelargonate, sodium caprate, sodium undecylate, sodium laurate, sodium tridecylate, sodium myristate, sodium pentadecylate, sodium palmitate, sodium margarate, sodium stearate, sodium benzoate, disodium adipate, disodium maleate, disodium phthalate, sodium 2-hydroxybutyrate, sodium 3-hydroxybutyrate, sodium 2-oxobutyrate, sodium gluconate, methanesulfonate, sodium glycer ... Examples of betaines include sodium sulfonate, sodium 1-nonanesulfonate, sodium 1-decanesulfonate, sodium 1-dodecanesulfonate, sodium 1-undecanesulfonate, sodium cocoyl isethionate, sodium lauroyl methylalanine, sodium cocoyl methyl taurate, sodium cocoyl glutamate, sodium cocoyl sarcosine, sodium lauroyl methyl taurate, lauramidopropyl betaine, potassium isobutyrate, potassium propionate, potassium pivalate, potassium glycolate, potassium gluconate, potassium methanesulfonate, calcium stearate, calcium glycolate, calcium gluconate, calcium 3-methyl-2-oxobutyrate, and calcium methanesulfonate. Betaine is a general term for an intramolecular salt, specifically a compound in which three methyl groups are added to the amino group of an amino acid, and more specifically, trimethylglycine, carnitine, and proline betaine can be mentioned.
[0291] The water-soluble salt may further contain a monohydric alcohol or a polyhydric alcohol having 1 to 4 carbon atoms, and the alcohol is preferably selected from ethanol, isopropyl alcohol, ethylene glycol, diethylene glycol, triethylene glycol, glycerin, polyethylene glycol, polypropylene glycol, polyglycerin, diglycerin, and a silicone compound having a polyglycerin structure.
[0292] The pretreatment method using a salt-containing aqueous solution can wet the biocontact layer after the formation of the micropillars by spraying, dispensing water droplets, etc. It can also be wetted in a high temperature and high humidity state such as a sauna. After wetting, it can be covered with a sheet to prevent drying. Since the sheet needs to be peeled off just before applying it to the skin, it is coated with a release agent or a peelable fluororesin film is used. The dry electrode covered with a release sheet is sealed in a bag covered with aluminum or the like for long-term storage. In order to prevent drying in the aluminum-covered bag, it is preferable to seal moisture in it.
[0293] Wiping or spraying the skin on the side where the bioelectrode is to be attached with a cloth containing water or water-containing alcohol such as ethanol or glycerin immediately before attachment is effective in moistening the skin surface and obtaining highly sensitive and highly accurate biosignals in a shorter time. Wiping with the water-containing cloth not only moistens the skin, but also has the effect of removing oils and greases from the skin surface, which also improves the sensitivity of the biosignals.
[0294] As described above, the manufacturing method of the bioelectrode of the present invention makes it possible to easily manufacture, at low cost, the bioelectrode of the present invention which has excellent conductivity and biocompatibility, is lightweight, and whose conductivity does not decrease significantly whether it is wetted with water or dried. EXAMPLES
[0295] The present invention will be specifically described below using examples and comparative examples, but the present invention is not limited to these.
[0296] Ionic polymers 1 to 11, which were blended as ionic materials (conductive materials) in the bioelectrode composition solution, were synthesized as follows. A 30% by mass solution of each monomer in cyclopentanone was placed in a reaction vessel and mixed. The reaction vessel was cooled to -70°C under a nitrogen atmosphere, and degassed under reduced pressure and nitrogen blowing were repeated three times. After heating to room temperature, 0.01 mol of azobisisobutyronitrile (AIBN) was added as a polymerization initiator per 1 mol of the total monomers, and the mixture was heated to 60°C and reacted for 15 hours. The composition of the obtained polymer was as follows after drying the solvent: 1 The molecular weight (Mw) and dispersity (Mw / Mn) of the obtained polymer were confirmed by gel permeation chromatography (GPC) using tetrahydrofuran (THF) as a solvent. The ionic polymers 1 to 11 thus synthesized are shown below.
[0297] Ionic Polymer 1 Mw=39,600 Mw / Mn=1.94 [ka] (The number of repetitions in the formula indicates the average value.)
[0298] Ionic Polymer 2 Mw=46,800 Mw / Mn=1.92 [ka] (The number of repetitions in the formula indicates the average value.)
[0299] Ionic Polymer 3 Mw=39,600 Mw / Mn=1.82 [ka]
[0300] Ionic Polymer 4 Mw=44,100 Mw / Mn=1.91 [ka] (The number of repetitions in the formula indicates the average value.)
[0301] Ionic Polymer 5 Mw=49,200 Mw / Mn=2.22 [ka] (The number of repetitions in the formula indicates the average value.)
[0302] Ionic Polymer 6 Mw=46,000 Mw / Mn=2.31 [ka] (The number of repetitions in the formula indicates the average value.)
[0303] Ionic Polymer 7 Mw=45,700 Mw / Mn=2.01 [ka] (The number of repetitions in the formula indicates the average value.)
[0304] Ionic Polymer 8 Mw=52,300 Mw / Mn=2.21 [ka] (The number of repetitions in the formula indicates the average value.)
[0305] Ionic Polymer 9 Mw=32,700 Mw / Mn=1.81 [ka] (The number of repetitions in the formula indicates the average value.)
[0306] Ionic Polymer 10 Mw=46,400 Mw / Mn=2.13 [ka] (The number of repetitions in the formula indicates the average value.)
[0307] Ionic Polymer 11 Mw=36,400 Mw / Mn=2.03 [ka] (The number of repetitions in the formula indicates the average value.)
[0308] Ionic polymers 12 to 19 were synthesized as follows. Ionic polymers 12 to 19 were synthesized by mixing a dihydroxy group-containing fluorinated alkyl or aryl sulfonate compound or a dihydroxy group-containing fluorosulfonamide compound with an isocyanate compound, a dihydroxy compound for chain extension in some cases, a monohydroxy compound or a monoisocyanate compound for terminal blocking, a solvent propylene glycol monomethyl ether acetate in an amount twice the mass of the raw material compound, and 0.02 mass% of catalyst XK-640 (manufactured by KING INDUSTRIES) per 100 mass parts of the raw material compound, and reacting at 90°C for 9 hours.
[0309] Ionic Polymer 12 Mw=22,700 Mw / Mn=2.73 [ka] (In the formula, * represents a bond.)
[0310] Ionic Polymer 13 Mw=24,000 Mw / Mn=2.95 [ka] (In the formula, * represents a bond.)
[0311] Ionic Polymer 14 Mw=10,300 Mw / Mn=2.23 [ka] (In the formula, * represents a bond.)
[0312] Ionic Polymer 15 Mw=38,000 Mw / Mn=3.10 [ka] (In the formula, * represents a bond.)
[0313] Ionic Polymer 16 Mw=24,000 Mw / Mn=2.82 [ka] (In the formula, * represents a bond.)
[0314] Ionic Polymer 17 Mw=24,400 Mw / Mn=2.89 [ka] (In the formula, * represents a bond.)
[0315] Ionic Polymer 18 Mw=9,900 Mw / Mn=2.08 [ka] (In the formula, * represents a bond.)
[0316] Ionic Polymer 19 Mw=9,700 Mw / Mn=2.02 [ka] (In the formula, * represents a bond.)
[0317] The blended polyurethanes 1 and 2 incorporated into the bioelectrode solution are shown below.
[0318] Blended Polyurethane 1 Mw=21,000 Mw / Mn=2.62 [ka] (In the formula, * represents a bond.)
[0319] Blended Polyurethane 2 Mw=35,000 Mw / Mn=2.83 [ka] (In the formula, * represents a bond.)
[0320] The lithium titanate and the conductivity enhancer (carbon black, carbon nanotubes, graphite, silver powder, polyglycerin silicone 1) that were blended as additives in the bioelectrode composition solution are as follows.
[0321] Lithium titanate: Sigma-Aldrich Size: 200nm or less Carbon black: Denka Black Li-400 manufactured by Denka Carbon nanotubes: Sigma-Aldrich, diameter 110-170 nm, length 5-9 μm Graphite: Sigma-Aldrich, diameter 20 μm or less Silver powder: Sigma-Aldrich silver flakes, diameter 10 μm
[0322] Polyglycerin Silicone 1 [ka]
[0323] The solvents used in the bioelectrode solution are shown below. BE: Diethylene glycol monobutyl ether GBL: Gamma butyrolactone
[0324] [Examples 1 to 19, Comparative Examples 1 to 2] Ionic polymers, resins, solvents, and additives (lithium titanate, conductivity enhancer) were blended in the compositions shown in Tables 1 and 2 to prepare bioelectrode solutions (bioelectrode solutions 1 to 19, comparative bioelectrode solution 1).
[0325] [Table 1]
[0326] [Table 2]
[0327] (Preparation of conductive substrate X) As shown in FIG. 32, a conductive paste, Dotite FA-333, manufactured by Fujikura Chemical Industries, was coated on a polyethylene terephthalate (PET) film (substrate 4) having a thickness of 50 μm by screen printing, and the film was baked in an oven at 120° C. for 10 minutes to print a keyhole-shaped conductive pattern (conductive layer 3) having a circular diameter of 20 mm, thereby forming a conductive substrate X.
[0328] (Preparation of the biological contact layer) The bioelectrode solution shown in Tables 1 and 2 was stencil-printed on a PET substrate in a size of 25 mm × 100 mm to prepare an ionic polymer layer with a thickness of 150 to 300 μm. Similarly, the bioelectrode solution was applied by stencil printing onto the circular pattern of the conductive paste shown in Figure 32, as shown in Figure 33, to form a biocontact layer 2.
[0329] (Preparing the mold) A stainless steel mold was used, with holes formed in the layout shown in Fig. 11 and with the cross section shown in Fig. 14. The holes are aligned at an angle of 60 degrees to the horizontal, the pitch of the holes in the 60 degree direction is 200 μm, and the pillar height is 120 μm.
[0330] (Preparation of micropillar-type bioelectrodes) As shown in FIG. 34, the mold was heated to 120° C. and a pressure of 50 kg / cm was applied to each of the biological contact layers having a size of 25 mm×100 mm and a diameter of 20 mm. 2 After pressing for 5 minutes, the mold was peeled off to form a micropillar-shaped living body contact layer 2-1.
[0331] The 25mm x 100mm size was used to measure skin adhesion. It was attached to the skin on the inside of the upper arm with a pressure of 2kg, and then a peel test was performed at an angle of 180 degrees. The results are shown in Table 3.
[0332] (Biological signal measurement) The circle with a diameter of 20 mm shown in Fig. 34 was used for measuring biosignals (ECG). The three bioelectrodes in Fig. 34 were cut out and attached to the skin. Since the bioelectrode of Comparative Example 1 had no adhesive strength, the bioelectrode was attached to the skin with cellophane tape.
[0333] The ECG measuring device used was NeXus10 MARKII manufactured by Kissei Comtec Co., Ltd. In Fig. 35, the electrode 11 is a positive electrode, 12 is a negative electrode, and 13 is a ground electrode.
[0334] When the PQRST wave was observed in the ECG signal, the signal was judged to be good, and when it was not observed, the signal was judged to be poor. The results are shown in Table 3.
[0335] [Table 3]
[0336] As shown in Table 3, in Examples 1 to 19, which are bioelectrodes of the present invention, in which the biocontact layer has micropillars with diameters ranging from 0.01 to 500 μm and heights ranging from 0.1 to 1,000 μm, and the ionic polymer material forming the biocontact layer contains one or more repeating units a selected from fluorosulfonic acid, fluorosulfonimide, and fluorosulfonamide, and has a weight-average molecular weight ranging from 1,000 to 500,000, the adhesive strength was excellent and biosignals could be obtained.
[0337] On the other hand, in Comparative Example 1, a bioelectrode in which the biocontact layer does not have micropillars in the range of 0.01 to 500 μm in diameter and 0.1 to 1,000 μm in height, even if the ionic polymer of the material forming the biocontact layer contains one or more repeating units a selected from fluorosulfonic acid, fluorosulfonimide, and fluorosulfonamide and has a weight-average molecular weight in the range of 1,000 to 500,000, was able to obtain a biosignal but did not have adhesive power. In Comparative Example 2, a bioelectrode in which the biocontact layer does not use an ionic polymer as the material forming the biocontact layer, even if the bioelectrode has micropillars in the range of 0.01 to 500 μm in diameter and 0.1 to 1,000 μm in height, was able to obtain an adhesive power but did not have a biosignal.
[0338] The present specification includes the following aspects. [1]: A bioelectrode including a biocontact layer and a substrate, The biological contact layer has micropillars having a diameter of 0.01 to 500 μm and a height of 0.1 to 1,000 μm, and contains an ionic polymer (A) as a material; The component (A) comprises one or more repeating units a selected from fluorosulfonic acid, fluorosulfonimide, and fluorosulfonamide, and has a weight-average molecular weight in the range of 1,000 to 500,000. [2]: The bioelectrode according to the above [1], wherein the repeating unit a has a partial structure represented by the following general formulas (1)-1 to (1)-4. [ka] (In the formula, Rf1 and Rf2 are a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group. When Rf1 and Rf2 are oxygen atoms, Rf1 and Rf2 are one oxygen atom bonding to one carbon atom to form a carbonyl group. Rf3 and Rf4 are a hydrogen atom, a fluorine atom, or a trifluoromethyl group. One or more of Rf1 to Rf4 are a fluorine atom or a trifluoromethyl group. Rf5 is a fluorine atom, or a linear or branched alkyl group having 1 to 4 carbon atoms and has at least one fluorine atom. Rf6 and Rf7 are a linear, branched, or cyclic alkyl group having 1 to 10 carbon atoms which may be substituted with a fluorine atom, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms and has at least one fluorine atom. M + is an ion selected from an ammonium ion, a sodium ion, a potassium ion, and a silver ion; and m is an integer of 1 to 4. [3]: The bioelectrode according to the above [1] or [2], wherein the repeating unit a has one or more repeating units selected from the repeating units A1 to A4 represented by the following general formula (2): [ka] (In general formula (2), R 1 , R 3 , R 4 , and R 6 are each independently a hydrogen atom or a methyl group, R 2 , R 5 , and R 7are each independently a single bond, or a linear, branched or cyclic hydrocarbon group having 1 to 13 carbon atoms, and may have an ester group, an ether group, or both. X1, X2, X3, and X4 are each independently a single bond, a phenylene group, a naphthylene group, an ether group, an ester group, or an amide group. Rf1 and Rf2 are a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group, and when Rf1 and Rf2 are oxygen atoms, Rf1 and Rf2 are an oxygen atom that bonds to one carbon atom to form a carbonyl group, and Rf3 and Rf4 are a hydrogen atom, a fluorine atom, or a trifluoromethyl group, and at least one of Rf1 to Rf4 is a fluorine atom or a trifluoromethyl group. Rf5 is a fluorine atom, or a linear or branched alkyl group having 1 to 4 carbon atoms, and has at least one fluorine atom. Rf6 and Rf7 are a linear, branched or cyclic alkyl group having 1 to 10 carbon atoms, which may be substituted with a fluorine atom, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms, and have at least one fluorine atom. m is an integer of 1 to 4. a1, a2, a3 and a4 are each 0≦a1≦1.0, 0≦a2≦1.0, 0≦a3≦1.0 and 0≦a4≦1.0, and 0≦a1≦1.0 is an integer of 1 to 4. <a1+a2+a3+a4≦1.0である。M + is an ion selected from ammonium ion, sodium ion, potassium ion, and silver ion. [4]: The bioelectrode according to any one of [1] to [3] above, characterized in that the repeating unit a has one or more types selected from repeating units A5 to A7 represented by the following general formula (4): [ka] (In general formula (4), R 8 , R 10 , R 12 , R 14 , R 16 , and R 18 are each independently a single bond or a linear or branched alkylene group having 1 to 6 carbon atoms. 9 , R13 , and R 17 are each independently a hydrogen atom, a hydroxyl group, or a linear or branched alkyl group or alkoxy group having 1 to 6 carbon atoms. 11 , R 19 represents a single bond or a linear, branched or cyclic hydrocarbylene group having 1 to 20 carbon atoms, which may have one or more groups selected from a carbonyl group, an ether group and an ester group; R 8 , R 16 R may be bonded to form a ring. 15 is a single bond, or a linear, branched, or cyclic hydrocarbylene group having 1 to 20 carbon atoms, and may have one or more selected from a carbonyl group, an ether group, and an ester group. Rf1 and Rf2 are a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group, and when Rf1 and Rf2 are oxygen atoms, Rf1 and Rf2 are one oxygen atom bonding to one carbon atom to form a carbonyl group, Rf3 and Rf4 are a hydrogen atom, a fluorine atom, or a trifluoromethyl group, and at least one of Rf1 to Rf4 is a fluorine atom or a trifluoromethyl group. Rf5 is a fluorine atom, or a linear or branched alkyl group having 1 to 4 carbon atoms, and has at least one fluorine atom. Rf7 is a linear, branched or cyclic alkyl group having 1 to 10 carbon atoms which may be substituted with a fluorine atom, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms, and has at least one fluorine atom. m is an integer of 1 to 4. a5, a6 and a7 are each 0≦a5≦1.0, 0≦a6≦1.0 and 0≦a7≦1.0, and 0 is an integer of 1 to 4. <a5+a6+a7≦1.0である。M + is an ion selected from an ammonium ion, a sodium ion, a potassium ion, and a silver ion; p is 0 or 1, and q is 1 or 2. [5]: The bioelectrode according to any one of [2] to [4] above, characterized in that the repeating unit a contains an ammonium ion represented by the following general formula (3) as an ammonium ion constituting the ammonium salt: [ka] (In general formula (3), R 101d , R 101e , R 101f and R 101g R is a hydrogen atom, a linear, branched, or cyclic alkyl group having 1 to 15 carbon atoms, a linear, branched, or cyclic alkenyl group or alkynyl group having 2 to 12 carbon atoms, or an aromatic group having 4 to 20 carbon atoms, and may have one or more groups selected from an ether group, a carbonyl group, an ester group, a hydroxyl group, a carboxyl group, an amino group, a nitro group, a sulfonyl group, a sulfinyl group, a halogen atom, and a sulfur atom. 101d and R 101e , or R 101d , R 101e and R 101f may form a ring together with the nitrogen atom to which they are attached, and when they form a ring, R 101d and R 101e , or R 101d , R 101e and R 101f is an alkylene group having 3 to 10 carbon atoms, or forms a heteroaromatic ring having the nitrogen atom in the general formula (3) in the ring. [6]: Any one of the bioelectrodes [1] to [5] above, characterized in that the biocontact layer contains a resin other than the component (A) as the component (B) contained in the material of the biocontact layer. [7]: The bioelectrode according to the above [6], wherein the component (B) is at least one selected from the group consisting of silicone resins, (meth)acrylate resins, and urethane resins. [8]: A method for producing a bioelectrode according to any one of the above [1] to [7], characterized in that the micropillars are produced by inserting a resin containing the (A) component into a mold serving as a template and peeling the resin from the mold. [9]: A method for producing a bioelectrode according to any one of the above [1] to [7], characterized in that the micropillars are produced by inserting a resin containing the (A) component into a resin pattern that serves as a template, and dissolving the resin pattern with water or an alkaline aqueous solution to peel it off.
[0339] The present invention is not limited to the above-described embodiment. The above-described embodiment is merely an example, and anything that has substantially the same configuration as the technical idea described in the claims of the present invention and exhibits similar effects is included in the technical scope of the present invention. [Explanation of symbols]
[0340] 1...mold, 2...biocontact layer, 2-1...biocontact layer, 2-2...ionic polymer-containing solution, 3...conductive layer, 3-1...conductive pillar, 4...substrate, 5...resist layer, 6...dissolving layer, 7...substrate; 8...skin; 10...biological electrode; 11...positive electrode, 12...negative electrode, 13...earth.
Claims
1. A bioelectrode including a biocontact layer and a substrate, The biological contact layer has micropillars having a diameter of 0.01 to 500 μm and a height of 0.1 to 1,000 μm, and contains an ionic polymer (A) as a material; The component (A) comprises one or more repeating units a selected from fluorosulfonic acid, fluorosulfonimide, and fluorosulfonamide, and has a weight average molecular weight in the range of 1,000 to 500,000.
2. The bioelectrode according to claim 1, characterized in that the repeating unit a has a partial structure represented by the following general formulas (1)-1 to (1)-4. 【Chemistry 1】 (wherein, Rf 1 and Rf 2 is a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group, and Rf 1 and Rf 2 When Rf is an oxygen atom, 1 and Rf 2 is an oxygen atom bonded to a carbon atom to form a carbonyl group, and Rf 3 and Rf 4 is a hydrogen atom, a fluorine atom, or a trifluoromethyl group, and Rf 1 ~Rf 4 At least one of Rf is a fluorine atom or a trifluoromethyl group. 5 is a fluorine atom or a linear or branched alkyl group having 1 to 4 carbon atoms and having at least one fluorine atom. 6 and Rf 7 is a linear, branched or cyclic alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms, which may be substituted with a fluorine atom, and which has at least one fluorine atom. + is an ion selected from an ammonium ion, a sodium ion, a potassium ion, and a silver ion; and m is an integer from 1 to 4.
3. The bioelectrode according to claim 1, characterized in that the repeating unit a has one or more repeating units selected from the repeating units A1 to A4 represented by the following general formula (2): 【Chemistry 2】 (In general formula (2), R 1 , R 3 , R 4 , and R 6 are each independently a hydrogen atom or a methyl group, R 2 , R 5 , and R 7 are each independently a single bond or a linear, branched or cyclic hydrocarbon group having 1 to 13 carbon atoms, and may have an ester group, an ether group, or both. 1 , X 2 , X 3 , and X 4 Rf each independently represents a single bond, a phenylene group, a naphthylene group, an ether group, an ester group, or an amide group. 1 and Rf 2 is a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group, and Rf 1 and Rf 2 When Rf is an oxygen atom, 1 and Rf 2 is an oxygen atom bonded to a carbon atom to form a carbonyl group, and Rf 3 and Rf 4 is a hydrogen atom, a fluorine atom, or a trifluoromethyl group, and Rf 1 ~Rf 4 At least one of Rf is a fluorine atom or a trifluoromethyl group. 5 is a fluorine atom or a linear or branched alkyl group having 1 to 4 carbon atoms and having at least one fluorine atom. 6 and Rf 7 is a linear, branched or cyclic alkyl group having 1 to 10 carbon atoms which may be substituted with a fluorine atom, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms, and has at least one fluorine atom. m is an integer from 1 to 4. a1, a2, a3 and a4 are each within the range of 0≦a1≦1.0, 0≦a2≦1.0, 0≦a3≦1.0 and 0≦a4≦1.0, and 0<a1+a2+a3+a4≦1.
0. M + is an ion selected from ammonium ion, sodium ion, potassium ion, and silver ion.
4. The bioelectrode according to claim 1, characterized in that the repeating unit a has one or more repeating units selected from A5 to A7 represented by the following general formula (4). 【Chemistry 3】 (In general formula (4), R 8 , R 10 , R 12 , R 14 , R 16 , and R 18 are each independently a single bond or a linear or branched alkylene group having 1 to 6 carbon atoms. 9 , R 13 , and R 17 are each independently a hydrogen atom, a hydroxyl group, or a linear or branched alkyl group or alkoxy group having 1 to 6 carbon atoms. 11 , R 19 represents a single bond or a linear, branched or cyclic hydrocarbylene group having 1 to 20 carbon atoms, which may have one or more groups selected from a carbonyl group, an ether group and an ester group; R 8 , R 16 may be bonded to form a ring. 15 Rf is a single bond or a linear, branched, or cyclic hydrocarbylene group having 1 to 20 carbon atoms, and may have one or more groups selected from a carbonyl group, an ether group, and an ester group. 1 and Rf 2 is a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group, and Rf 1 and Rf 2 When Rf is an oxygen atom, 1 and Rf 2 is an oxygen atom bonded to a carbon atom to form a carbonyl group, and Rf 3 and Rf 4 is a hydrogen atom, a fluorine atom, or a trifluoromethyl group, and Rf 1 ~Rf 4 At least one of Rf is a fluorine atom or a trifluoromethyl group. 5 is a fluorine atom or a linear or branched alkyl group having 1 to 4 carbon atoms and having at least one fluorine atom. 7 is a linear, branched or cyclic alkyl group having 1 to 10 carbon atoms which may be substituted with a fluorine atom, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, or an aryl group having 6 to 10 carbon atoms, and has at least one fluorine atom. m is an integer from 1 to 4. a5, a6 and a7 are each within the range of 0≦a5≦1.0, 0≦a6≦1.0, 0≦a7≦1.0, and 0<a5+a6+a7≦1.
0. M + is an ion selected from an ammonium ion, a sodium ion, a potassium ion, and a silver ion; p is 0 or 1, and q is 1 or 2.
5. 3. The bioelectrode according to claim 2, wherein the repeating unit a contains an ammonium ion represented by the following general formula (3) as an ammonium ion constituting the ammonium salt: 【Chemistry 4】 (In general formula (3), R 101d , R 101e , R 101f and R 101g are each a hydrogen atom, a linear, branched, or cyclic alkyl group having 1 to 15 carbon atoms, a linear, branched, or cyclic alkenyl group or alkynyl group having 2 to 12 carbon atoms, or an aromatic group having 4 to 20 carbon atoms, and may have one or more groups selected from an ether group, a carbonyl group, an ester group, a hydroxyl group, a carboxyl group, an amino group, a nitro group, a sulfonyl group, a sulfinyl group, a halogen atom, and a sulfur atom. 101d and R 101e , or R 101d , R 101e and R 101f may form a ring together with the nitrogen atom to which they are attached, and when they form a ring, R 101d and R 101e , or R 101d , R 101e and R 101f is an alkylene group having 3 to 10 carbon atoms, or forms a heteroaromatic ring having the nitrogen atom in the general formula (3) in the ring.
6. 2. The bioelectrode according to claim 1, wherein the material of the biological contact layer contains a resin other than the component (A) as the component (B).
7. 7. The bioelectrode according to claim 6, wherein the component (B) is at least one selected from the group consisting of silicone resins, (meth)acrylate resins, and urethane resins.
8. A method for producing a bioelectrode according to any one of claims 1 to 7, characterized in that the micropillars are produced by inserting a resin containing the component (A) into a mold serving as a template and peeling the resin from the mold.
9. A method for producing a bioelectrode according to any one of claims 1 to 7, characterized in that the micropillars are produced by inserting a resin containing the (A) component into a resin pattern that serves as a template, and dissolving the resin pattern with water or an alkaline aqueous solution to peel it off.
Citation Information
Patent Citations
Conductive millable urethane rubber electrode
JP1993095924A
Silicone rubber composition for living body electrode and electrode for living body
JP2003225217A
Biocompatible electrode structure and manufacturing method therefor, and device and manufacturing method therefor
JP2015019806A
Clothing for bioelectric signal monitor
JP2015100673A
Bioelectrode composition, bioelectrode, method for producing bioelectrode, and polymer compound
JP2018126496A
